Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
2020 Annual Scientific Meeting | Calgary, Alberta
Share |


The 2020 CPS 41st Annual Scientific Meeting will create a forum in which scientists, healthcare professionals, and trainees from clinical, educational, research, policy and industry settings can meet and exchange up-to-date information on pain mechanisms, pain assessment, and pain management. This event promotes core values of professionalism and competency-based education and advocates on behalf of patients with acute and chronic pain. This year’s event is not to be missed!


Conference Registration Opening Soon!




David Bennett, MB., Ph.D, Professor of Neurology and Neurobiology. Head of the Division of Clinical Neurology, Senior Wellcome Clinical Scientist, Honorary Consultant Neurologist, Research Fellow of Greem Templeton College.

"My research aim is to gain a better understanding of the response of the nervous system to injury in order to develop strategies to promote peripheral nerve repair and to prevent the development of neuropathic pain. This is complementary to my clinical interest in peripheral neuropathy and pain management.

I administer a specialist neuropathy and channelopathy clinical service at the Oxford University Hospitals Foundation Trust. I employ a multi-disciplinary approach including electrophysiology, cell culture, preclinical transgenic models and transcriptional profiling as well as biomarker, psychophysical and genetic studies in patients.

This research programme is leading to a better understanding of the signaling events which lead to neuropathic pain, improved means of patient stratification and led to new drug targets which are undergoing clinical trials.

I have been involved in understanding the genetic basis of inherited painful channelopathies (for instance familial episodic pain syndrome due to TRPA1 mutations as well as rare variants in Nav1.7) and in the description and validation of novel pain mediators such as NGF and CXCL5.

I am a member of the London Pain Consortium and I lead DOLORisk a Horizon 20.20 initiative with 11 participating centres which is investigating the risk factors and determinants of neuropathic pain. Iwas awarded an honorary Skou Professorship at the University of Aarhus 2019. "



Sarah E. Ross., Ph.D Associate Professor, Neurobiology and Anesthesiology

Bio to follow - stay tuned!




Sean Mackey, M.D., Ph.D, is Chief of the Division of Pain Medicine, Director of the Systems Neuroscience and Pain Laboratory (SNAPL) and Redlich Professor of Anesthesiology, Perioperative and Pain Medicine, Neurosciences and (by courtesy) Neurology at Stanford University.

Dr. Mackey is the Immediate Past President of the American Academy of Pain Medicine. he received his BSE and MSE in Bioengineering from the University of Pennsylvania and his Ph.D. in Electrical and Computer Engineering as well as MD from the University of Arizona. Dr. Mackey is the author of over 200 journal articles, book chapters, abstracts, and popular press pieces in addition to numerous national and international lectures.

Under Dr. Mackey’s leadership, the Stanford Pain Management Center has been designated a Center of Excellence by the American Pain Society, one of only two centers to receive this honor twice. In 2011 he was a member of the Institutes of Medicine committee that issued the report on Relieving Pain in America. He is currently Co-Chair of the Oversight Committee for the NIH/Health and Human Services National Pain Strategy, an effort to establish a national health strategy for pain care, education and research.

Under Dr. Sean Mackey’s leadership, researchers at the Stanford Pain Management Center and the Stanford Systems Neuroscience and Pain Laboratory (SNAPL) have made major advances in the understanding of chronic pain as a disease in its own right, one that fundamentally alters the nervous system. Dr. Mackey has overseen efforts to map the specific brain and spinal cord regions that perceive and process pain, which has led to the development of a multidisciplinary treatment model that translates basic science research into innovative therapies to provide more effective, personalized treatments for patients with chronic pain.

                           We look forward to seeing you in Calgary!